Genolution Inc. (KOSDAQ:225220)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,810.00
-8.00 (-0.44%)
At close: Feb 20, 2026
Market Cap32.70B -31.4%
Revenue (ttm)9.15B +25.6%
Net Income-8.06B
EPS-446.41
Shares Out18.07M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume48,515
Average Volume88,931
Open1,807.00
Previous Close1,818.00
Day's Range1,805.00 - 1,821.00
52-Week Range1,755.00 - 3,015.00
Beta0.16
RSI36.57
Earnings DateMar 20, 2026

About Genolution

Genolution Inc. manufactures and sells IVD medical instruments in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and double-stranded RNA (dsRNA) synthesis technology. The company offers Nextractor NX-Duo, Nextractor NX-32N/45N, Nextractor NX-Jr, Nextractor NX-24SA, NGS library preparation equipment, DNA/RNA extraction kits. It also develops and manufactures instruments and reagents for DNA/RNA; provides long dsRNA synthesis services; and siRNA/miRNA/sh... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2006
Employees 75
Stock Exchange KOSDAQ
Ticker Symbol 225220
Full Company Profile

Financial Performance

In 2024, Genolution's revenue was 7.14 billion, a decrease of -26.90% compared to the previous year's 9.76 billion. Losses were -6.83 billion, 23.8% more than in 2023.

Financial Statements